首页> 外文OA文献 >Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1
【2h】

Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1

机译:通过与突变体早老素1不同的机制,衰老增加淀粉样蛋白肽并引起旧app / V717I转基因小鼠脑中的淀粉样蛋白斑。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Aging of transgenic mice that overexpress the London mutant of amyloid precursor protein (APP/V717I) (Moechars et al., 1999a) was now demonstrated not to affect the normalized levels of a-or beta-cleaved secreted APP nor of the beta-C-terminal stubs. This indicated that aging did not markedly disturb either alpha- or beta-secretase cleavage of APP and failed to explain the origin of the massive amounts of amyloid peptides A beta 40 and A beta 42, soluble and precipitated as amyloid plaques in the brain of old APP/V717I transgenic mice. We tested the hypothesis that aging acted on presenilin1 (PS1) to affect gamma-secretase-mediated production of amyloid peptides by comparing aged APP/V717I transgenic mice to double transgenic mice coexpressing human PS1 and APP/V717I. In double transgenic mice with mutant (A246E) but not wild-type human PS1, brain amyloid peptide levels increased and resulted in amyloid plaques when the mice were only 6-9 months old, much earlier than in APP/V717I transgenic mice (12-15 months old). Mutant PS1 increased mainly brain A beta 42 levels, whereas in aged APP/V717I transgenic mice, both A beta 42 and A beta 40 increased. This resulted in a dramatic difference in the A beta 42/A beta 40 ratio of precipitated or plaque-associated amyloid peptides, i.e., 3.11 +/- 0.22 in double APP/V717I x PS1/A246E transgenic mice compared with 0.43 +/- 0.07 in aged APP/V717I transgenic mice, and demonstrated a clear difference between the effect of aging and the effect of the insertion of a mutant PS1 transgene. In conclusion, we demonstrate that aging did not favor amyloidogenic over nonamyloidogenic processing of APP, nor did it exert a mutant PS1-like effect on gamma-secretase. Therefore, the data are interpreted to suggest that parenchymal and vascular accumulation of amyloid in aging brain resulted from failure to clear the amyloid peptides rather than from increased production.
机译:现在证明过表达淀粉样蛋白前体蛋白的伦敦突变体(APP / V717I)的转基因小鼠的衰老(Moechars等,1999a)不会影响α-或β-切割的分泌APP或β-C的标准化水平。 -终端存根。这表明衰老并没有明显干扰APP的α-或β-分泌酶的裂解,也无法解释大量淀粉样肽A beta 40和A beta 42的起源,可溶解并沉淀为老年人大脑中的淀粉样斑块。 APP / V717I转基因小鼠。我们通过比较衰老的APP / V717I转基因小鼠和共表达人PS1和APP / V717I的双转基因小鼠,测试了衰老作用于presenilin1(PS1)来影响γ-分泌酶介导的淀粉样肽生产的假说。在具有突变体(A246E)但没有野生型人PS1的双转基因小鼠中,当小鼠只有6-9个月大时,脑淀粉样肽水平增加并导致淀粉样斑块,比APP / V717I转基因小鼠早得多(12- 15个月大)。突变PS1主要增加大脑A beta 42的水平,而在衰老的APP / V717I转基因小鼠中,A beta 42和A beta 40均增加。这导致沉淀的或与斑块相关的淀粉样肽的A beta 42 / A beta 40比值发生显着差异,即双APP / V717I x PS1 / A246E转基因小鼠中的3.11 +/- 0.22与0.43 +/- 0.07相比在衰老的APP / V717I转基因小鼠中获得了成功,并且证明了衰老的影响与突变PS1转基因的插入之间存在明显的差异。总而言之,我们证明了衰老过程不支持淀粉样蛋白生成而不是非淀粉样蛋白生成APP,它也不会对γ-分泌酶产生突变的PS1样作用。因此,数据被解释为表明老化的大脑中淀粉样蛋白的实质和血管蓄积是由于未能清除淀粉样蛋白肽而不是产量增加所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号